NAN vs RCE

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NAN

NANOSONICS FPO [NAN]

52MEDIUM

RCE

RECCE LTD FPO [RCE]

40LOW

Score Breakdown

NAN RCE
Technical
49
54
Catalyst
53
62
Sentiment
50
50
Fundamental
94
23
Momentum
41
50
Risk Gate
40
45

Key Metrics

NAN Metric RCE
$965.5MMarket Cap$113.8M
440KAvg Volume (20d)323K
+6.9%Short InterestN/A
$4.77052-Week High$0.730
$2.96052-Week Low$0.310
-0.3%Daily Change-2.6%
$3.220Reference Price$0.380
+10.1%ROEN/A
+9.9%Profit MarginN/A

Active Signals

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

RCE Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Sitting near support — this level has held before and could attract buyers again
●Lagging the Small Ords index — relative strength of 0.80, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.1 quarters)
●Very high P/S ratio (116.8x)
●Revenue in sharp decline (-94%)

Ask Scout AI to compare NAN and RCE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NAN vs SLD →NAN vs SNT →NAN vs SPL →NAN vs TRJ →NEU vs PAR →
NAN Full Analysis → RCE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).